These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24116392)

  • 1. "Deconstruction" of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter.
    Kolanos R; Solis E; Sakloth F; De Felice LJ; Glennon RA
    ACS Chem Neurosci; 2013 Dec; 4(12):1524-9. PubMed ID: 24116392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.
    Cameron KN; Kolanos R; Solis E; Glennon RA; De Felice LJ
    Br J Pharmacol; 2013 Apr; 168(7):1750-7. PubMed ID: 23170765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.
    Cameron K; Kolanos R; Vekariya R; De Felice L; Glennon RA
    Psychopharmacology (Berl); 2013 Jun; 227(3):493-9. PubMed ID: 23371489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-conserved residues dictate dopamine transporter selectivity for the potent synthetic cathinone and psychostimulant MDPV.
    Steele TWE; Spires Z; Jones CB; Glennon RA; Dukat M; Eltit JM
    Neuropharmacology; 2021 Dec; 200():108820. PubMed ID: 34619165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters.
    Solis E
    Curr Top Behav Neurosci; 2017; 32():73-92. PubMed ID: 27677783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
    Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
    Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats.
    Kolanos R; Partilla JS; Baumann MH; Hutsell BA; Banks ML; Negus SS; Glennon RA
    ACS Chem Neurosci; 2015 May; 6(5):771-7. PubMed ID: 25688761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter.
    Shekar A; Aguilar JI; Galli G; Cozzi NV; Brandt SD; Ruoho AE; Baumann MH; Matthies HJG; Galli A
    J Chem Neuroanat; 2017 Oct; 83-84():69-74. PubMed ID: 28163218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption.
    Blum K; Foster Olive M; Wang KK; Febo M; Borsten J; Giordano J; Hauser M; Gold MS
    Med Hypotheses; 2013 Sep; 81(3):450-5. PubMed ID: 23845561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
    Anneken JH; Angoa-Pérez M; Kuhn DM
    J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters.
    Magee CP; German CL; Siripathane YH; Curtis PS; Anderson DJ; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2020 Aug; 374(2):273-282. PubMed ID: 32385092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.
    Baumann MH; Partilla JS; Lehner KR; Thorndike EB; Hoffman AF; Holy M; Rothman RB; Goldberg SR; Lupica CR; Sitte HH; Brandt SD; Tella SR; Cozzi NV; Schindler CW
    Neuropsychopharmacology; 2013 Mar; 38(4):552-62. PubMed ID: 23072836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP).
    Glennon RA; Young R
    Brain Res Bull; 2016 Sep; 126(Pt 1):111-126. PubMed ID: 27142261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine.
    Lopez-Arnau R; Duart-Castells L; Aster B; Camarasa J; Escubedo E; Pubill D
    Psychopharmacology (Berl); 2019 Mar; 236(3):925-938. PubMed ID: 30284596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of monoaminergic mechanisms to the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) in Sprague-Dawley rats.
    Risca HI; Baker LE
    Psychopharmacology (Berl); 2019 Mar; 236(3):963-971. PubMed ID: 30554256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) and structurally related synthetic cathinones.
    Seaman RW; Doyle MR; Sulima A; Rice KC; Collins GT
    Behav Pharmacol; 2021 Aug; 32(5):357-367. PubMed ID: 33587482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.
    Baumann MH; Bukhari MO; Lehner KR; Anizan S; Rice KC; Concheiro M; Huestis MA
    Curr Top Behav Neurosci; 2017; 32():93-117. PubMed ID: 27830575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional connectivity, behavioral and dopaminergic alterations 24 hours following acute exposure to synthetic bath salt drug methylenedioxypyrovalerone.
    Colon-Perez LM; Pino JA; Saha K; Pompilus M; Kaplitz S; Choudhury N; Jagnarine DA; Geste JR; Levin BA; Wilks I; Setlow B; Bruijnzeel AW; Khoshbouei H; Torres GE; Febo M
    Neuropharmacology; 2018 Jul; 137():178-193. PubMed ID: 29729891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.
    Simmons SJ; Gregg RA; Tran FH; Mo L; von Weltin E; Barker DJ; Gentile TA; Watterson LR; Rawls SM; Muschamp JW
    Addict Biol; 2018 Jan; 23(1):102-110. PubMed ID: 27910188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture.
    Harvey EL; Baker LE
    Psychopharmacology (Berl); 2016 Feb; 233(4):673-80. PubMed ID: 26558618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.